71 – 80 of 164
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2004
-
Mark
Epidemiology of osteoporotic fractures.
(
- Contribution to journal › Article
-
Mark
Raloxifene reduces risk of vertebral fractures and breast cancer in postmenopausal women regardless of prior hormone therapy.
(
- Contribution to journal › Article
-
Mark
Epidemiology of osteoporosis and fracture in men
(
- Contribution to journal › Article
-
Mark
An estimate of the worldwide prevalence, mortality and disability associated with hip fracture.
(
- Contribution to journal › Article
-
Mark
A family history of fracture and fracture risk: a meta-analysis
(
- Contribution to journal › Article
-
Mark
Mortality after osteoporotic fractures.
(
- Contribution to journal › Article
-
Mark
Cost effectiveness of raloxifene in the treatment of osteoporosis in Sweden - An economic evaluation based on the MORE study
(
- Contribution to journal › Article
-
Mark
Cost effectiveness of alendronate for the treatment of male osteoporosis in Sweden.
(
- Contribution to journal › Article
-
Mark
Nationellt Kompetenscentrum for Ortopedi - NKO
(
- Contribution to journal › Article
-
Mark
Long term effects of oestrogen therapy on bone loss in postmenopausal women: a 23 year prospective study.
(
- Contribution to journal › Article